synthetic
-
Biologics
Acuitive Technologies Receives FDA 510(k) Clearance for CITREPORE™, A New Synthetic Bioactive Bone Void Filler for Orthopedic Procedures
ALLENDALE, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — Acuitive Technologies, Inc. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market CITREPORE, a…
Read More » -
Spine
Orthofix Announces 510k Clearance and Full Commercial Launch of OsteoCove, an Advanced Bioactive Synthetic Graft for use in Spine and Orthopedic Procedures
LEWISVILLE, TX, October 12, 2023 /OrthoSpineNews/ Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510k…
Read More » -
Biologics
Biocomposites invests in Renovos Biologics – developers of the RENOVITE® nanoclay therapeutic delivery platform
RENOVITE ® nanoclay is a novel therapeutic delivery platform for precision regenerative medicine Investment will help fund pre-market approval for use in…
Read More » -
Biologics
PUR Biologics Announces Launch of PURcore™, a bioActive Moldable Synthetic for Spine Surgery
IRVINE, CA., April 6, 2023 /OrthoSpineNews/ – PUR Biologics, a subsidiary of HippoFi, Inc. (OTC Pink: ORHB), is proud to…
Read More » -
Biologics
Ventris Medical Receives 510(k) Clearance for Amplify® Standalone Bone Graft Putty and Bone Graft Extender
NEWPORT BEACH, Calif., Sept. 14, 2022 /PRNewswire/ — Ventris Medical, a privately held orthobiologics and tissue regeneration company, today announced that the…
Read More » -
Biologics
Orthofix Expands Synthetic Bone Growth Offerings with Full Market Launch of Opus BA – a Bioactive Solution for Spine Procedures
February 22, 2022 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Biologics
Orthofix Launches O-GENESIS Graft Delivery System and New Hydrated, Ready-to-Use AlloQuent Structural Allograft Q-PACK
October 7, 2020 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus,…
Read More » -
Biologics
OrthoPediatrics Corp. Announces U.S. Launch of QuickPack™
WARSAW, Ind., Dec. 20, 2019 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of…
Read More » -
Extremities
Paragon 28® Launches Unique Option for Revising a Failed Synthetic Cartilage Implant (SCI)
ENGLEWOOD, Colo., Dec. 13, 2019 /PRNewswire/ — Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery.…
Read More » -
Sports Medicine
Northwestern Scientists Create Synthetic Bone Using 3-D Printer
Kristen Thometz | September 28, 2016 New technology developed in Chicago could lead to major advances in healing broken bones…
Read More » -
Extremities
Cartiva, Inc. Announces First US Procedure for FDA Approved Cartiva Synthetic Cartilage Implant
July 12, 2016 ALPHARETTA, Ga.–(BUSINESS WIRE)–Cartiva, Inc. announced today that the first commercial U.S. patient has received the Cartiva…
Read More » -
Hospitals
Cartiva, Inc. Announces FDA Premarket Approval for Cartiva Synthetic Cartilage Implant
July 05, 2016 ALPHARETTA, Ga.–(BUSINESS WIRE)–Cartiva, Inc., a developer of innovative products for the treatment of cartilage damage and…
Read More » -
Hospitals
Cartiva Announces Publication of Results of Cartiva Synthetic Cartilage Implant Pivotal Study
(Alpharetta, GA, May 17, 2016) – Cartiva, Inc., (Company) a developer of innovative solutions for the treatment of cartilage damage,…
Read More » -
Extremities
FDA Questions First PMA for Synthetic Cartilage Implant Ahead of Advisory Panel
Posted 18 April 2016 By Zachary Brennan The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health…
Read More » -
Spine
Alphatec Spine Launches Alphatec Neocore(TM) Osteoconductive Matrix in the U.S.
CARLSBAD, Calif., Oct. 01, 2015 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a…
Read More »
